← Back to all earnings calls

Serina Therapeutics, Inc. Q3 FY2024 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2024 Q3 Call date: 2024-11-12 Concluded

Share

Quarter scorecard

Revenue

$14,000

-51.7% YoY

Diluted EPS

$0.13

-43.5% YoY

Net income

$1.41M

-19.5% YoY

Documents & deck